Article Type
Changed
Fri, 01/04/2019 - 11:40
Display Headline
Allogeneic Stem Cell Transplant

Dr. Sergio Giralt discusses his findings that suggest age should no longer be a contraindication to allogeneic stem cell transplantation. Dr. Armand Keating, press conference moderator, comments on the implications of this study during a briefing at the annual meeting of the American Society of Hematology.

Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Dr. Sergio Giralt discusses his findings that suggest age should no longer be a contraindication to allogeneic stem cell transplantation. Dr. Armand Keating, press conference moderator, comments on the implications of this study during a briefing at the annual meeting of the American Society of Hematology.

Dr. Sergio Giralt discusses his findings that suggest age should no longer be a contraindication to allogeneic stem cell transplantation. Dr. Armand Keating, press conference moderator, comments on the implications of this study during a briefing at the annual meeting of the American Society of Hematology.

Publications
Publications
Topics
Article Type
Display Headline
Allogeneic Stem Cell Transplant
Display Headline
Allogeneic Stem Cell Transplant
Article Source

PURLs Copyright

Inside the Article